IPM

Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.

Molecular Formula: C₁₂H₁₉N₃O₅S

InChI: InChI=1/C12H17N3O4S.H2O/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17;/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19);1H2/t6-,7-,9-;/m1./s1/f/h18H,13H2;/b14-5+;

InChIKey: InChIKey=GSOSVVULSKVSLQ-MRCSPMPADY
SMILES: CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.O

Names:
    D00206
    Imipenem (JP15/USP)
    imipenem
    IPM
    (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate
    74431-23-5

Registries:
    PubChem CID 5282372
    PubChem ID 7847274